Johnson & Johnson blames price cuts in India for poor show in knee-implant business

The company's medical device business, which reported total Q3 revenue of $6.6 billion, saw the knee implant business decline to $343 million from $355 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news